Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim D Janda

Showing results (251-260 of 342) with videos related to

Pageof 35
Sort By:
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
ACS Medicinal Chemistry Letters|November 28, 2012
3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasBAmanda L Garner, Anjali K Struss, Jessica L Fullagar, et al.
Journal of Medicinal Chemistry|May 4, 2011
Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulusAmanda L Garner, Christian Gloeckner, Nancy Tricoche, et al.
Bioorganic & Medicinal Chemistry|December 24, 2013
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chainHajime Seki, Sabine Pellett, Peter Silhár, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Vaccination against weight gainEric P Zorrilla, Shinichi Iwasaki, Jason A Moss, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Enhancing nicotine vaccine immunogenicity with liposomesJonathan W Lockner, Sam On Ho, Karen C McCague, et al.
Chemistry & Biology|May 26, 2007
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibilityNicholas R Silvaggi, Grant E Boldt, Mark S Hixon, et al.
Biochemistry|May 30, 2018
Crystallography Coupled with Kinetic Analysis Provides Mechanistic Underpinnings of a Nicotine-Degrading EnzymeMargarita A Tararina, Song Xue, Lauren C Smith, et al.
FEBS Letters|December 4, 2010
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1Christina L Pier, Chen Chen, William H Tepp, et al.
ACS Infectious Diseases|October 28, 2024
Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication StudiesEalin N Patel, Lucy Lin, Hyeri Park, et al.
Pageof 35

Showing results (251-260 of 342) with videos related to

Sort By:
Pageof 35
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
ACS Medicinal Chemistry Letters|November 28, 2012
3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasBAmanda L Garner, Anjali K Struss, Jessica L Fullagar, et al.
Journal of Medicinal Chemistry|May 4, 2011
Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulusAmanda L Garner, Christian Gloeckner, Nancy Tricoche, et al.
Bioorganic & Medicinal Chemistry|December 24, 2013
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chainHajime Seki, Sabine Pellett, Peter Silhár, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Vaccination against weight gainEric P Zorrilla, Shinichi Iwasaki, Jason A Moss, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Enhancing nicotine vaccine immunogenicity with liposomesJonathan W Lockner, Sam On Ho, Karen C McCague, et al.
Chemistry & Biology|May 26, 2007
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibilityNicholas R Silvaggi, Grant E Boldt, Mark S Hixon, et al.
Biochemistry|May 30, 2018
Crystallography Coupled with Kinetic Analysis Provides Mechanistic Underpinnings of a Nicotine-Degrading EnzymeMargarita A Tararina, Song Xue, Lauren C Smith, et al.
FEBS Letters|December 4, 2010
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1Christina L Pier, Chen Chen, William H Tepp, et al.
ACS Infectious Diseases|October 28, 2024
Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication StudiesEalin N Patel, Lucy Lin, Hyeri Park, et al.
Pageof 35